Free Trial

Moderna (MRNA) Earnings Date, Estimates & Call Transcripts

Moderna logo
$39.39 -0.17 (-0.43%)
(As of 12/20/2024 05:45 PM ET)

Moderna Latest Earnings Summary

Actual EPS
(Nov. 7)
$0.03 Beat By $1.92
Consensus EPS
(Nov. 7)
-$1.89

Moderna issued Q3 2024 earnings on November 7, 2024, reporting an EPS of $0.03, which beat the consensus estimate of -$1.89 by $1.92. Quarterly revenue rose 3.8% year-over-year to $1.90 billion, above the consensus estimate of $1.25 billion. With a trailing EPS of -$5.82, Moderna's earnings are expected to grow next year, from ($9.30) to ($8.85) per share.

Get Moderna Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Moderna and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

MRNA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MRNA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Moderna Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20244-$3.49-$1.86-$2.66
Q2 20244-$3.47-$1.85-$3.02
Q3 20244-$1.88$0.10-$0.97
Q4 20244-$1.83$1.60-$0.38
FY 202416-$10.67-$2.01-$7.02
Q1 20251-$2.90-$2.90-$2.90
Q2 20251-$3.11-$3.11-$3.11
Q3 20252-$1.44$1.30-$0.07
Q4 20252-$1.25$1.36$0.06
FY 20256-$8.70-$3.35-$6.03
Q1 20261-$2.68-$2.68-$2.68
Q2 20261-$2.76-$2.76-$2.76
Q3 20261-$0.72-$0.72-$0.72

Moderna Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/7/2024Q3 2024-$1.89$0.03+$1.92$0.03$1.25B$1.90B
8/1/2024Q2 2024-$3.47-$3.33+$0.14-$3.33$128.41M$241.00M
5/2/2024Q1 2024-$3.59-$3.07+$0.52-$3.07$93.26M$167.00M
2/22/2024Q4 2023-$0.78$0.55+$1.33$0.55$2.53B$2.80B
11/2/2023Q3 2023-$2.01-$1.39+$0.62$6.75$1.37B$1.83B
8/3/2023Q2 2023-$3.84-$3.62+$0.22-$3.62$307.67M$344.00M
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]
5/4/2023Q1 2023-$1.77$0.19+$1.96$0.19$1.17B$1.86B
2/23/2023Q4 2022$4.66$3.61 -$1.05$3.61$5.02B$5.08B

Moderna Earnings - Frequently Asked Questions

Moderna (NASDAQ:MRNA) last announced its quarterly earning data on Thursday, November 7, 2024. Learn more on MRNA's earnings history.

In the previous quarter, Moderna (NASDAQ:MRNA) reported $0.03 earnings per share (EPS) to beat the analysts' consensus estimate of ($1.89) by $1.92. Learn more on analysts' earnings estimate vs. MRNA's actual earnings.

The conference call for Moderna's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Moderna's latest earnings report can be read online.
Read Transcript

Moderna (NASDAQ:MRNA) has a recorded annual revenue of $6.85 billion.

Moderna (NASDAQ:MRNA) has a recorded net income of -$4.71 billion. MRNA has generated -$5.82 earnings per share over the last four quarters.

Moderna's earnings are expected to grow from ($9.30) per share to ($8.85) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:MRNA) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners